Fair enough. Thanks for the heads up. Your opening post was lacking some important detail, which you have since elaborated upon. Either way doesn't make too much difference, I'll be holding fast, up until my shares are compulsory acquired, with an independent evaluation.
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution